Whalegun
Home

Sukumar Nagendran, President and Head of R&D: Taysha Gene Therapies TSHA Sell · Filed 01/27

Trade details

Type
Insider sale
Amount
$124,091.98
Shares · price
26,918 sh · $4.61 a share
Held after
1,317,389 sh
Stock
Taysha Gene Therapies TSHA
Person
Sukumar NagendranPresident and Head of R&D
Trade date
26/01/26
Filed
26/01/27
Days to filing
1 days

Sold 2.0% of holdings

Share of holding sold
2.0%

Taysha Gene Therapies trades, last 26 weeks

What else happened in Taysha Gene Therapies around then

Filed or reported within 30 days of the trade day · 25/12/27~02/25

Sukumar Nagendran's recent trades

  • Sukumar Nagendran

    Planned sale10b5-1 planTaysha Gene Therapies

    $1.3M

    Filed 07/10

  • Sukumar Nagendran

    Sell10b5-1 planTaysha Gene Therapies

    $892K

    Filed 04/13

  • Sukumar Nagendran

    Planned sale10b5-1 planTaysha Gene Therapies

    $926K

    Filed 04/10

  • Sukumar Nagendran

    SellTaysha Gene Therapies

    $423.4K

    Filed 01/27

  • Sukumar Nagendran

    Planned saleTaysha Gene Therapies

    $579.4K

    Filed 01/23